SCHEMBL949785

SCHEMBL949785

CC(=O)OCc1cccc(C(=O)OC(C)(C)C)n1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.44
MRGPRX4 Q96LA9 5/20 0.40
ALDH1A1 P00352 2/20 0.39
MAPT P10636 1/20 0.37
CYP2C19 P33261 1/20 0.37
SLC7A5 Q01650 1/20 0.36
HPGDS O60760 1/20 0.36
ELANE P08246 2/20 0.36
PARP1 P09874 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.35
GABRP O00591 1/20 0.35
GABRD O14764 1/20 0.35
GABRA1 P14867 1/20 0.35
GABRB1 P18505 1/20 0.35
GABRG2 P18507 1/20 0.35
GABRB3 P28472 1/20 0.35
GABRA5 P31644 1/20 0.35
GABRA3 P34903 1/20 0.35
GABRA2 P47869 1/20 0.35
GABRB2 P47870 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL949804 0.82 CYP1A2 (0.45) CYP1A2MRGPRX4ALDH1A1MAPTSLC7A5
SCHEMBL12359170 0.82 CYP1A2 (0.49) CYP1A2MRGPRX4ALDH1A1MAPTSLC7A5
SCHEMBL31098592 0.82 CYP1A2 (0.45) CYP1A2MRGPRX4ALDH1A1MAPTSLC7A5
SCHEMBL29844105 0.81 CYP1A2 (0.44) CYP1A2MRGPRX4ALDH1A1MAPTSLC7A5
SCHEMBL948907 0.81 CYP1A2 (0.44) CYP1A2MRGPRX4ALDH1A1MAPTCYP2C19
SCHEMBL14686051 0.81 CYP1A2 (0.44) CYP1A2MRGPRX4ALDH1A1MAPTSLC7A5
SCHEMBL2352200 0.81 CYP1A2 (0.44) CYP1A2MRGPRX4ALDH1A1MAPTSLC7A5
SCHEMBL946894 0.79 POLB (0.46) PARP1
SCHEMBL9298499 0.79 MBOAT4 (0.44) CYP1A2MRGPRX4ALDH1A1CYP2C19
SCHEMBL23970505 0.79 CYP4F2 (0.40) CYP1A2MRGPRX4ALDH1A1MAPTSLC7A5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7989446-B2 4-amino 5-cyanopyrimidine derivatives OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2011-08-02 US disclosed
US-20110009620-A1 4-Amino-5-cyanopyrimidine derivatives OTSUKA PHARMACEUTICAL CO., LTD. 2011-01-13 US disclosed
US-7834002-B2 4-amino-5-cyanopyrimidine derivatives OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2010-11-16 US disclosed
US-20080182854-A1 4-Amino-5-Cyanopyrimidine Derivatives OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2008-07-31 US disclosed
EP-1740574-B1 4-AMINO-5-CYANOPYRIMIDINE DERIVATIVES OTSUKA PHARMA CO LTD (JP) 2007-06-27 EP disclosed
EP-1740574-A2 4-AMINO-5-CYANOPYRIMIDINE DERIVATIVES Otsuka Pharmaceutical Company, Limited (JP) 2007-01-10 EP disclosed
WO-2005105778-A2 4-AMINO-5-CYANOPYRIMIDINE DERIVATIVES OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2005-11-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110009620-A1 4-Amino-5-cyanopyrimidine derivatives ADORA2A, ADORA1, ADORA3 CYP1A2 497/4885MRGPRX4 115/4885ALDH1A1 381/4885
US-20080182854-A1 4-Amino-5-Cyanopyrimidine Derivatives ADORA2A, ADORA1, ADORA3 CYP1A2 497/4885MRGPRX4 115/4885ALDH1A1 381/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.